Condition: Duchenne Muscular Dystrophy (DMD) · Sponsor: Shanghai Jiao Tong University School of Medicine
The purpose of this study is to evaluate the safety, tolerability, and efficacy of LE051 intravenous therapy in DMD patients treated with exon 51 skipping therapy.
This description comes directly from the study's public registry record.
Jiwen Wang · +86 189 1661 3192 · wangjiwen@scmc.com.cn
Always discuss trial participation with your own doctor first.
| Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06900049